Thomas M Wheeler

发表

Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.

Hartwig Huland, Markus Graefen, Michael W Kattan, 2003, The Journal of urology.

Metabolomic signatures of aggressive prostate cancer

Yair Lotan, Y. Lotan, J. McDunn, 2013, The Prostate.

Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.

Michael W Kattan, Victor E Reuter, M. Kattan, 2006, The Journal of urology.

Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.

Wei Huang, Kenneth A Iczkowski, K. Iczkowski, 2011, American journal of clinical pathology.

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Samir S Taneja, Paul Schellhammer, H Ballentine Carter, 2013, The Journal of urology.

Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features.

Michael Phillips, T. Wheeler, R. Cohen, 2008, The Journal of urology.

Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

T. Wheeler, S. Shariat, B. Miles, 2004, The Journal of urology.

The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Anna Frolov, J. Sowadski, T. Wheeler, 2003, Cancer research.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling

Lars Egevad, Rodolfo Montironi, Brett Delahunt, 2011, Modern Pathology.

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

J Wade Harper, Guang Yang, Timothy C Thompson, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomas.

T. Wheeler, M. Sayeeduddin, K. Hellström, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Do Adenocarcinomas of the Prostate With Gleason Score (GS)⩽6 Have the Potential to Metastasize to Lymph Nodes?

Janet E Cowan, J. Epstein, T. Wheeler, 2012, The American journal of surgical pathology.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins

Liang Cheng, Lars Egevad, Rodolfo Montironi, 2011, Modern Pathology.

A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis.

T. Wheeler, D. C. Malins, E. Barker, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Predictors of prostate cancer after initial negative systematic 12 core biopsy.

T. Wheeler, S. Shariat, B. Miles, 2004, The Journal of urology.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Anthony Rhodes, Lisa M McShane, Soonmyung Paik, 2006, Archives of pathology & laboratory medicine.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume

Lars Egevad, Rodolfo Montironi, Mahul B Amin, 2011, Modern Pathology.

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Michael W Kattan, Kazumasa Matsumoto, M. Kattan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reporting guidelines for clinical laboratory reports in surgical pathology.

Saul Suster, Jeffrey D Goldsmith, S. Suster, 2008, Archives of pathology & laboratory medicine.

Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.

Katarzyna J Macura, John Kurhanewicz, Jeffrey D Blume, 2009, Radiology.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease

Rodolfo Montironi, Brett Delahunt, Cristina Magi-Galluzzi, 2011, Modern Pathology.

Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.

Victor Reuter, Mithat Gonen, Colin B Begg, 2003, The Journal of urology.

Imaging , Diagnosis , Prognosis Prognostic Value of Akt1 in Human Prostate Cancer : A Computerized Quantitative Assessment with Quantum Dot Technology

Hong Dai, Anna Frolov, P. Scardino, 2009 .

Improved prediction of prostate cancer recurrence through systems pathology.

Mikhail Teverovskiy, Angeliki Kotsianti, Yevgen Vengrenyuk, 2007, The Journal of clinical investigation.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Anthony Rhodes, Lisa M McShane, Soonmyung Paik, 2007, Archives of pathology & laboratory medicine.

Evaluating localized prostate cancer and identifying candidates for focal therapy.

Mark A Rubin, Jonathan Coleman, Hedvig Hricak, 2008, Urology.

Cancer control with radical prostatectomy alone in 1,000 consecutive patients.

Michael W Kattan, Farhat Abbas, M. Kattan, 2002, The Journal of urology.

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Oliver Sartor, John Trachtenberg, Michel Rossignol, 2007, The Journal of urology.

A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.

Michael W Kattan, Kazuho Suyama, M. Kattan, 2003, The Journal of urology.